Long-term opioid therapy for non-cancer pain has increased. Caution is advised in prescribing for persons with substance use disorders, but little is known about actual health plan practices. This paper reports trends and characteristics of long-term opioid use in persons with non-cancer pain and a substance abuse history. Using health plan data (1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005), the study compared age-sex-standardized rates of incident, incident long-term and prevalent long-term prescription opioid use, and medication use profiles in those with and without substance use disorder histories. The CONsortium to Study Opioid Risks and Trends study included adult enrollees of two health plans, Kaiser Permanente of Northern California (KPNC) and Group Health Cooperative (GH) of Seattle, Washington. At KPNC (1999KPNC ( -2005, prevalence of longterm use increased from 11.6% to 17.0% for those with substance use disorder histories and from 2.6% to 3.9% for those without substance use disorder histories. Respective GH rates (1997-2005, increased from 7.6% to 18.6% and from 2.7% to 4.2%. Among persons with an opioid disorder, KPNC rates increased from 44.1% to 51.1%, and GH rates increased from 15.7% to 52.4%. Long-term opioid users with a prior substance abuse diagnosis received higher dosage levels, were more likely to use Schedule II and longacting opioids, and were more often frequent users of sedative-hypnotic medications in addition to their opioid use. Since these patients are viewed as higher risk, the increased use of long-term opioid therapy suggests the importance of improved understanding of the benefits and risks of opioid therapy among persons with a history of substance abuse, and the need for more careful screening for substance abuse history than is the usual practice. Ó
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Introduction
In the last several years, opioid treatment for non-cancer pain has increased dramatically in the U.S. [8, 23] . High rates of prescription drug abuse have also heightened concern about the prescribing practices and potential adverse effects [11, 40] . Although drug testing of U.S. workers between 1997 and 2007 showed declining rates for most drug use, in contrast, rates of opiate use increased from 11% to 16%. However, it is not known whether this was due to prescription abuse [9] .
Expert guidelines for management of non-cancer pain recommend caution in prescribing long-term opioid therapy for persons with a substance use disorder, but also recognize the importance of treating their pain [21] . However, little is known about medically prescribed use in community practice for individuals with substance abuse histories. A recent review [29] found only one study measuring rates of narcotic analgesic use for those with a substance abuse history. A recent study of long-term opioid management in primary care practices found the prevalence of substance abuse disorders to be 9.7% and opioid disorders to be 3.8% among those with daily opioid prescription use, but it did not examine them prior to the prescribed opioid use [19] .
The efficacy and risks of long-term opioid use for individuals with substance abuse histories are poorly understood, because they have been excluded from almost all randomized trials of long-term opioid therapy [10, 25, 34, 41] . In line with expert
